MONIQUE MALLOY: Open Payments
NPI 1346900594 · JOHNSTOWN, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$372 in 20 payments from 11 companies in 2025. Trend: 2023 $959 · 2024 $1,191 · 2025 $372
Food & beverage: $372
| Company | Payments | Amount |
|---|---|---|
| Vifor Pharma, Inc. | 5 | $92 |
| Amgen Inc. | 4 | $78 |
| Novartis Pharmaceuticals Corporation | 2 | $44 |
| AstraZeneca Pharmaceuticals LP | 2 | $29 |
| Calliditas Therapeutics US Inc. | 1 | $25 |
| OPKO Pharmaceuticals, LLC | 1 | $20 |
| Mallinckrodt Hospital Products Inc. | 1 | $19 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $18 |
| Otsuka America Pharmaceutical, Inc. | 1 | $17 |
| Novo Nordisk Inc | 1 | $16 |
Products named: Veltassa, KRYSTEXXA, Fabhalta, FARXIGA, TARPEYO, RAYALDEE, ACTHAR, Kerendia.
Industry payments across PA — which companies pay providers there.
